Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Leptomeningeal Carcinomatosis- A case with a mismatch of clinical and radiological picture.
Neuro-oncology
P4 - Poster Session 4 (5:30 PM-6:30 PM)
13-002
To describe a case of leptomeningeal carcinomatosis(LC) with elevated intracranial pressure(ICP) and normal brain Magnetic resonance imaging (MRI).
LC is a rare condition with leptomeningeal spread where tumor cells reach the leptomeninges by direct extension or by hematogenous spread and are then disseminated throughout the neuro-axis by cerebrospinal fluid (CSF). It is more commonly seen with hematopoietic tumors and less common with solid tumors. MRI brain and CSF analysis are key in diagnosing LC. 

We report a case of  a 34-year-old female with a history of metastatic ovarian cancer on chemotherapy with FOLFOX who presented with of altered mental status (AMS) and seizures. Levetiracetam was initiated and she was admitted to the hospital. Patient notably had intermittent dilated non-reactive left pupil. MRI brain did not reveal any acute pathology or abnormal enhancement. Lumbar puncture (LP) was done and showed an elevated ICP >55 cm H2O, normal protein and significantly low glucose (18 mg/dl). CSF analysis was negative for infectious workup and was positive for cytology with concern for metastatic adenocarcinoma. She had an external ventricular drain placed and had fluctuating ICPs. Her hospital course was complicated with worsening mental status and electrographic seizures for which lacosamide and phenytoin were introduced. She had ventriculo-peritoneal (VP) shunt placement due to fluctuating ICPs. She continued to have worsening mental status and decline in respiratory status. She was eventually made comfort care and deceased.

A mismatch in clinical and radiological picture was seen in this patient who had objective evidence of raised ICP with AMS and pupillary abnormalities however normal neuro imaging.

There should be a high suspicion of raised ICP secondary to LC in a patient with malignancy and focal neurological deficits even with normal neuro imaging. Caution should be maintained with LP as this can lead to herniation.

Authors/Disclosures
Varun Kumar Pala, MD
PRESENTER
Dr. Pala has nothing to disclose.
Andrea S. Synowiec, DO, FÂé¶¹´«Ã½Ó³»­ (Allegheny Health Network) Dr. Synowiec has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Synowiec has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven.
Sandeep S. Rana, MD, FÂé¶¹´«Ã½Ó³»­ (Allegheny Health Network) Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSI. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmawrite. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.